Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety

LONDON, November 11 - The healthcare market is facing a severe downturn due to adverse effects
of the global economic slowdown. Costs for healthcare are reaching
unprecedented heights, and the neurophysiological monitoring market is no
exception. Market players in this industry have been faced with developments
such as the decline in prices, limited technological advancements in
hardware, high replacement costs, exchange rates fluctuations as well as
rising competition and a lack of government spending in the healthcare
sector.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

In its upcoming Quarterly Analyst Briefing 2009 Frost & Sullivan will
therefore focus on the market for Neurophysiological Monitoring Equipment.
The analyst briefing will be held on Thursday, 19th November 2009, at 2 p.m.
GMT and highlights will include an analysis of current trends and challenges
which are driving as well as restraining the market, significant developments
in the market and the road ahead.

"The neurophysiological monitoring market is in a mature stage, but the
steady rise of neuropsychiatric disorders and the need to monitor the central
and peripheral nervous system of patients has increased interest as well as
demand for neurophysiological monitors," says Somsainathan C. Kamalasekar,
Research Associate at Frost & Sullivan.

Companies in the market are forced to enhance their after sales service
policy in order to defy competition and to attract new customers. They also
need to understand the high receptiveness for technological upgradation among
end users and that there is increased spending on R&D activities. At the same
time, competition in the market is making the market players weigh the
options of strategic alliances with competitors and technology suppliers to
have an efficient sales network across different geographic regions and to
increase the market share.

"Neurophysiological feature highest forms of patient safety as they are
used during surgeries and in critical care units. Furthermore,
neurophysiological monitoring equipment used in surgical and pharmaceutical
treatments is considered to increase awareness among anaesthesiologists,
orthopaedic surgeons, intensive care specialists, otolaryngologists, vascular
surgeons, and interventional radiologists. Consequently it is expected to
offer a better platform for growth for the players in the neurophysiological
monitors market," concludes Somsainathan. C. Kamalasekar.

Frost & Sullivan will hold this conference call at 2 p.m. GMT on
Thursday, 19th November 2009, which will demonstrate the potential of
neurophysiological monitoring equipment. To participate, please email Katja
Feick at katja.feick@frost.com with the following information: your full
name, company name, title, telephone number, e-mail address, city, state, and
country. Upon receipt of the above information, a registration link will be
emailed to you.

About Frost & Sullivan:

Frost & Sullivan, the Growth Partnership Company, partners with clients
to accelerate their growth. The company's TEAM Research, Growth Consulting
and Growth Team Membership empower clients to create a growth-focused culture
that generates, evaluates and implements effective growth strategies. Frost &
Sullivan employs over 45 years of experience in partnering with Global 1000
companies, emerging businesses and the investment community from more than 35
offices on six continents. For more information about Frost & Sullivan's
Growth Partnerships, visit www.frost.com

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49-(0)-69-77-0-33-43
    F: +49-(0)-69-23-45-66
    E: katja.feick@frost.com

www.frost.com

Katja Feick of Frost & Sullivan Corporate Communications - Europe, +49-(0)-69-77-0-33-43, fax, +49-(0)-69-23-45-66, katja.feick at frost.com